| Interleukin-1β inhibition for chronic kidney disease in obese mice with type 2 diabetes Y Lei, SK Devarapu, M Motrapu, CD Cohen, MT Lindenmeyer, S Moll, ... Frontiers in immunology 10, 444740, 2019 | 63 | 2019 |
| Advanced-glycation end-products induce podocyte injury and contribute to proteinuria R Nishad, V Tahaseen, R Kavvuri, M Motrapu, AK Singh, K Peddi, ... Frontiers in Medicine 8, 685447, 2021 | 31 | 2021 |
| Inhibitors of calcium oxalate crystallization for the treatment of oxalate nephropathies A Kletzmayr, SR Mulay, M Motrapu, Z Luo, HJ Anders, ME Ivarsson, ... Advanced Science 7 (8), 1903337, 2020 | 30 | 2020 |
| Epigenomic and transcriptional profiling identifies impaired glyoxylate detoxification in NAFLD as a risk factor for hyperoxaluria K Gianmoena, N Gasparoni, A Jashari, P Gabrys, K Grgas, A Ghallab, ... Cell Reports 36 (8), 2021 | 25 | 2021 |
| Drug testing for residual progression of diabetic kidney disease in mice beyond therapy with metformin, ramipril, and empagliflozin M Motrapu, MK ¦widerska, I Mesas, JA Marschner, Y Lei, LM Valenzuela, ... Journal of the American Society of Nephrology 31 (8), 1729-1745, 2020 | 25 | 2020 |
| Growth hormone induces mitotic catastrophe of glomerular podocytes and contributes to proteinuria R Nishad, D Mukhi, AK Singh, M Motrapu, K Chintala, P Tammineni, ... Cell Death & Disease 12 (4), 342, 2021 | 22 | 2021 |
| Tubular epithelial cell HMGB1 promotes AKI-CKD transition by sensitizing cycling tubular cells to oxidative stress: A rationale for targeting HMGB1 during AKI recovery ZB Zhao, JA Marschner, T Iwakura, C Li, M Motrapu, M Kuang, B Popper, ... Journal of the American Society of Nephrology 34 (3), 394-411, 2023 | 12 | 2023 |
| Podocyte derived TNF‐α mediates monocyte differentiation and contributes to glomerular injury R Nishad, D Mukhi, S Kethavath, S Raviraj, ASV Paturi, M Motrapu, ... The FASEB Journal 36 (12), e22622, 2022 | 9 | 2022 |
| Epithelial-mesenchymal transition of glomerular podocytes: implications in proteinuria R Nishad, K Nakuluri, M Motrapu, AK Pasupulati MGM J Med Sci 4 (1), 1-9, 2017 | 7 | 2017 |
| No NLRP3 inflammasome activity in kidney epithelial cells, not even when the NLRP3-A350V Muckle-Wells variant is expressed in podocytes of diabetic mice SC Kunte, JA Marschner, M Klaus, T Honda, C Li, M Motrapu, C Walz, ... Frontiers in Immunology 14, 1230050, 2023 | 3 | 2023 |
| Neutrophil circadian rhythm is associated with different outcomes of acute kidney injury due to cholesterol crystal embolism C Shi, D Zhao, L Lyubenov, M Motrapu, N Li, S Steiger, ... Frontiers in Cardiovascular Medicine 9, 974759, 2022 | 2 | 2022 |
| Drug Testing for Chronic Kidney Disease and Diabetes in Animals versus Humans: A Comparative Analysis of Study Designs and Reporting Qualities V Könn, M Motrapu, MK ¦widerska, HJ Anders Nephron 146 (5), 503-513, 2022 | 1 | 2022 |
| Abstract PR009: Linking VHL and SETD2 in a common oncogenic pathway that converges on the mitotic spindle R Dere, P Chowdhury, SY Jung, R Aboulhassane, M Motrapu, X Wang, ... Cancer Research 83 (16_Supplement), PR009-PR009, 2023 | | 2023 |
| # 2863 SEX-, AGING AND DIABETES-RELATED ALTERATIONS IN GLOMERULAR DIMENSIONS AND PODOCYTE DENSITIES USING DEEP-LEARNING QUANTIFICATION M Klaus, M Motrapu, S Steiger, HJ Anders Nephrology Dialysis Transplantation 38 (Supplement_1), gfad063c_2863, 2023 | | 2023 |
| Die Rolle des NLRP3-Inflammasoms in der Pathogenese der Hyperfiltrations-induzierten CKD bei Diabetes mellitus Typ 1 SC Kunte, J Marschner, M Motrapu, PJ Nelson, HJ Anders Diabetologie und Stoffwechsel 17 (S 01), P 087, 2022 | | 2022 |
| IDF21-0092 Influence of the NLRP3 inflammasome in podocytes on the pathogenesis of diabetes dependent hyperfiltration-induced CKD S Kunte, J Marschner, M Motrapu, PJ Nelson, HJ Anders Diabetes Research and Clinical Practice 186, 2022 | | 2022 |
| Growth hormone induces TNF-α in podocytes and contributes to monocyte-to-macrophage differentiation: Implications in Diabetic kidney disease AK Pasupulati, R Nishad, D Mukhi, S Kethavath, S Raviraj, M Motrapu, ... | | 2022 |
| Re: Epigenomic and Transcriptional Profiling Identifies Impaired Glyoxylate Detoxification in NAFLD as a Risk Factor for Hyperoxaluria K Gianmoena, N Gasparoni, A Jashari, P Gabrys, K Grgas, A Ghallab, ... JOURNAL OF UROLOGY 207 (2), 462-462, 2022 | | 2022 |
| Pathogenesis: Hemodynamic Alterations MJ Soler, C Jacobs-Cachá, M Motrapu, HJ Anders Diabetes and Kidney Disease, 75-104, 2022 | | 2022 |
| FO051 Glycogen synthase kinases 3-α/β inhibition attenuates progression of diabetic kidney disease beyond treatment with metformin/Ramipril/empagliflozin L Anguiano Gómez, M Motrapu, J Marschner, HJ Anders Nephrology Dialysis Transplantation 34 (Supplement_1), gfz096. FO051, 2019 | | 2019 |
Hans-Joachim AndersLudwig Maximilians University MunichVerified email at med.uni-muenchen.de
